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RESEARCH
De Novo sphingolipid synthesis is 
essential for Salmonella-induced autophagy 




Background: Sphingolipids are important for innate immune response to eliminate infected pathogens and 
involved in autophagy. On the other hand, nucleotide‑binding oligomerization domain‑containing protein 2 (NOD2) 
served as an intracellular pattern recognition receptor to enhance host defense by inducing autophagy and the 
production of antimicrobial peptides, such as human beta‑defensin‑2 (hBD‑2). However, the role of sphingolipids in 
Salmonella‑induced autophagy and hBD‑2 response in intestinal epithelial cells has not been previously elucidated.
Methods: Salmonella typhimurium wild‑type strain SL1344 was used to infect SW480, an intestinal epithelial cell. 
hBD‑2 and interleukin‑8 (IL‑8) mRNA expressions were assessed in SW480 cells using RT‑PCR, and intracellular signal‑
ing pathways and autophagy protein expression were analyzed by Western blot in SW480 cells in the presence or 
absence of inhibitors or transfected with siRNA.
Results: We demonstrated that inhibition of de novo sphingolipid synthesis repressed the membrane recruitment of 
NOD2 and autophagy‑related protein 16‑like 1 (Atg16L1), suppressed Salmonella‑induced autophagic protein LC3‑II 
expression, and reduced NOD2‑mediated hBD‑2 response in Salmonella‑infected SW480 cells. Contrasting to the 
utilization of membrane cholesterol on maintenance of Salmonella‑containing vacuoles and anti‑inflammation by 
Salmonella, sphingolipids act on epithelial defense against the invasive pathogen.
Conclusions: Our results offer mechanistic insights on the role of de novo sphingolipid synthesis in the innate immu‑
nity of intestinal epithelial cells to Salmonella infection. The pharmaceuticals enhancing or diet enriched with sphin‑
golipids may induce the dual anti‑bacterial mechanisms. The role of de novo sphingolipid synthesis on inflammatory 
bowel disease is deserved to be further investigated.
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Background
Salmonella spp. remain a major public health problem for 
the whole world. A better understanding of host defense 
mechanisms of these food-borne pathogens is a prerequi-
site to design efficient strategies that could reduce the use 
of antimicrobial agents and drug-resistant Salmonellosis.
Recent studies highlight the importance of sphingolip-
ids in regulation of bacterial infections [1, 2]. Sphin-
golipids are important for innate immune response to 
eliminate infected pathogens and play a crucial role in 
infectious diseases [3]. On the other hand, sphingolipids 
are involved in the regulation of autophagy [4] and might 
potentially be novel targets for therapeutic intervention 
in human diseases [5]. For example, sphingolipid synthe-
sis is involved in autophagy in Saccharomyces cerevisiae 
[6]. Nucleotide-binding oligomerization domain-con-
taining protein 2 (NOD2) recruiting autophagy-related 
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protein 16-like 1 (ATG16L1) to the plasma membrane 
is critical for the autophagic response to invasive bacte-
ria [7, 8]. Additionally, Voss, et al. reported that NOD2 
served as an intracellular pattern recognition receptor 
to enhance host defense by inducing the production of 
antimicrobial peptides such as human beta-defensin-2 
(hBD-2) [9]. Human beta-defensin-2 an antimicrobial 
peptide induced in various epithelia (e.g. skin, respira-
tory tract, digestive tract, and genitourinary tract) upon 
extracellular as well as intracellular bacterial challenge, 
exhibits a broad spectrum of antimicrobial activity and 
has been demonstrated to kill bacteria in vivo [10], sug-
gesting that it is an important in host defense against 
microbes. Sphingolipids and cholesterol act in concert 
to form raft nanodomains and contribute to Akt/PKB 
plasma membrane recruitment and activation [11]. 
Nevertheless, they did not specify the action of sphin-
golipids and cholesterol. Salmonella protects epithelial 
cells from apoptosis by activation of Akt [12] to form 
Salmonella-containing vacuoles (SCVs), thus escaping 
from autophagy [13]. Recently, it was observed plasma 
membrane cholesterol plays a critical role on Salmo-
nella-induced autophagy [14]. However, the effects 
of membrane sphingolipids on Salmonella-induced 
autophagy and hBD-2 in intestinal epithelial cells (IECs) 
have not been investigated before. It is mandatory to 
exploit the exact effects of the membrane sphingolip-
ids in IECs infected by Salmonella. In the present work, 
we examine if membrane sphingolipids play a crucial 
role on the Salmonella-induced autophagy and hBD-2 
response in IECs via NOD2.
Results
Inhibition of de novo sphingolipid synthesis suppresses 
autophagy proteins expression of Salmonella‑infected 
SW480 cells
Sphingolipids are a class of bioactive lipids that medi-
ate many key cellular processes, including apoptosis 
and autophagy [15]. However, the importance of sphin-
golipids on Salmonella-induced autophagy in intestinal 
epithelial cells (IECs) has not been reported. To inves-
tigate the role of sphingolipids in autophagy proteins 
expression of IECs infected by Salmonella, myriocin 
which inhibits serine-palmitoyl transferase (the first 
step in sphingolipid biosynthesis) was used for deple-
tion of sphingolipids. The effectiveness of the inhibitor 
was confirmed as previously described [16–18]. Myriocin 
reduced the cellular amounts of glucosylceramide, the 
major glycosphingolipid in cultured cells, by more than 
90 %, as determined by TLC. Overnight starved SW480 
cells were untreated or treated by myriocin (10  µM 
myriocin for 48 h) and then infected by S. typhimurium 
wild-type strain SL1344 for the indicated time. The con-
version of LC3-I to LC3-II was detected by Western 
blot analysis and LC3+ autophagosome was analyzed by 
immunofluorescence. As shown in Fig.  1, Salmonella-
induced autophagy in SW480 cell was accompanied 
with an increase in the conversion of LC3-I to LC3-II 
(Fig.  1a, b) and increased LC3 punctae-containing cells 
in immunofluorescent analysis (Fig. 1c), while inhibition 
of sphingolipid synthesis by myriocin suppressed Salmo-
nella-induced LC3-II protein and LC3+ autophagosome 
expressions in SW480 cells. It suggests that inhibition 
of de novo sphingolipid synthesis with myriocin sup-
presses the autophagic process in Salmonella-infected 
SW480 cells. To confirm the suppressive effect of myri-
ocin on autophagy proteins expression, SW480 cells were 
untreated or treated by myriocin and then infected by S. 
typhimurium wild-type strain SL1344 for the indicated 
time. The autophagy Beclin-1 and Atg5 proteins expres-
sion was analyzed by immunoblot. It was observed that 
myriocin significantly suppressed Salmonella-induced 
Beclin-1 and Atg5 proteins expression in SW480 cells 
(Additional file 1: Figure S1).
Intracellular bacterial count is increased 
in Salmonella‑infected SW480 cells in the presence 
of myriocin
To investigate if inhibition of de novo sphingolipid syn-
thesis suppressed autophagic clearance of the intracel-
lular bacteria in Salmonella-infected IECs, SW480 cells 
were infected by S. typhimurium wild-type strain SL1344 
in the presence or absence of myriocin. Gentamicin pro-
tection assay was performed as in Experimental section. 
(see figure on next page) 
Fig. 1 Effect of myriocin on the expression of autophagy in Salmonella‑infected SW480 cells. SW480 cells were untreated (CON) or treated with 
myriocin and then infected by S. typhimurium wild‑type strain SL1344. Immunoblots were performed on whole cell lysates with antibody to detect 
autophagy LC3‑I/II protein expression, or GAPDH for normalization of proteins. Representative immunoblots (a) and densitometric quantification 
of immunoreactive bands are shown. The relative band intensities of LC3‑II (b) in untreated (white) and treated (black) SW480 cells are quantified 
as fold increases compared with the control cells. c SW480 cells were transfected with control siRNA or Atg16L1 siRNA (siAtg16L1 (−) = non‑target 
control siRNA; siAtg16L1(+) = siRNA to Atg16L1) for 48 h. The transfected cells were infected for 1 h with S. typhimurium wild‑type strain SL1344 in 
the absence or presence of myriocin. The cells were fixed, permeabilized and stained with anti‑LC3 (red) and LC3 puncta formation was detected by a 
confocal microscope. Representative images of LC3 punctae are depicted. Scale bar = 10 μm. d The percentage of cells showing accumulation of LC3 
punctae is reported. Each value represents the mean ± S.E.M. of 3 independent experiments. An asterisk indicates a significant difference (p < 0.05)
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As demonstrated in Fig. 2, myriocin increases the intra-
cellular bacterial count in SW480 cells comparing to the 
infection only or vehicle-treated cells.
Inhibition of de novo sphingolipid synthesis suppresses 
Salmonella‑induced membrane recruitment of NOD‑2 
and Atg16L1 in SW480 cells
NOD2 is critical for the autophagic response to invasive 
bacteria because they recruit ATG16L1 to the plasma 
membrane at the bacterial entry sites [7, 8]. However, 
the effect of sphingolipid on the membrane recruit-
ment of NOD2 or Atg16L1 is not clear. As demon-
strated in Fig. 3, Salmonella induced NOD2 and Atg16L1 
recruitment into membrane while myriocin sup-
pressed recruitment of Atg16L1 and NOD2 into mem-
brane. Additionally, SW480 cells were observed to have 
decreased LC3 +  autophagosome expression when they 
were transfected with NOD2 or Atg16L1. It suggests that 
the decreased recruitment of NOD2 and Atg16L1 to the 
plasma membrane contributes to the suppressive effect 
of myriocin on Salmonella-induced autophagy in IECs.
Inhibition of de novo sphingolipid synthesis suppresses 
Salmonella‑induced NOD‑2 mediated hBD‑2 expression 
in SW480 cells
As shown above, inhibition of de novo sphingolipid syn-
thesis with myriocin suppressed the membrane recruit-
ment of NOD2. Membrane targeting of NOD2 in 
intestinal epithelial cells is required for NOD2-depend-
ent NF-κB signaling [19] and subsequent inflammatory 
responses. NOD2 was reported to induce the produc-
tion of antimicrobial peptide hBD-2 [9]. It is hypoth-
esized that inhibition of de novo sphingolipid synthesis 
might suppress Salmonella-induced NOD2-mediated 
hBD-2 in IECs. To confirm this hypothesis, two stud-
ies were performed. The first, to study NOD2 mediates 
Salmonella-induced hBD-2 response in IECs, SW480 
cells were transfected with control nonsilencing siRNA 
or siRNA targeting NOD2 and infected by S. typhimu-
rium wild-type strain SL1344. The uninfected cells 
worked as control. The knockdown of NOD2 in SW480 
cells was demonstrated in Fig. 4a by Western blot (42 %, 
p < 0.05). As illustrated in Fig. 4b, NOD2 siRNA-trans-
fected SW480 cells had significantly less hBD-2 mRNA 
expression comparing to control siRNA-transfected 
ones. Secondly, to study if myriocin suppresses Salmo-
nella-induced hBD-2 response in IECs, overnight starved 
SW480 cells were uninfected or infected by S. typhimu-
rium wild-type strain SL1344 in the presence or absence 
of myriocin. As illustrated in Fig. 4c, Salmonella SL1344 
induces hBD-2 expression in SW480 cells while myri-
ocin suppresses the Salmonella-induced hBD-2 mRNA 
expression. It suggests inhibition of de novo sphingolipid 
synthesis with myriocin blocks Salmonella- induced 
NOD2 recruitment into membrane (Fig.  3) and subse-
quent suppression of hBD-2 expressions (Fig. 4).
Inhibition of de novo sphingolipid synthesis results 
in activation of Akt in Salmonella‑infected SW480 cells
Sphingolipids and cholesterol act in concert for the for-
mation of nanodomains [11] that play a crucial role in 
triggering the phosphatidyl-inositol-3-kinase (PI3  K)/
Akt signaling pathway. Salmonella protects epithelial 
cells from apoptosis by activation of Akt [12]. Besides, 
sphingolipid regulates apoptosis through the activation 
of extracellular growth factor-regulated kinase (ERK) 
Fig. 2 Effect of myriocin on the intracellular proliferation of S. typhimurium in cultured IECs. SW480c cells were left untreated, or treated with 
myriocin or PBS (vehicle), and then infected with wild‑type S. Typhimurium strain SL1344 and the levels of bacterial proliferation were examined 
60 min after infection as indicated in Experimental Section. Lysed cell cultures were plated on LB to count CFUs. Values represent the percentage 
of intracellular bacteria compared with the wild type without any treatment (assigned as 100 %). Each value represents the mean ± S.E.M. of 3 
independent experiments. An asterisk indicates a significant difference (p < 0.05)
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[20] and JNK [21]. It is reasonable to speculate that mem-
brane sphingolipids may also play a role on Salmonella-
induced apoptosis in IECs through the modulation of 
Akt, ERK or JNK signaling pathway. To investigate the 
role of sphingolipids in activation of Akt, ERK and JNK 
of IECs infected by Salmonella, overnight starved SW480 
cells were untreated or treated by myriocin (10 µM myri-
ocin for 48 h) and then infected by wild-type Salmonella 
Fig. 3 Effect of myriocin on the membrane recruitment of NOD2 and Atg16L1 in Salmonella‑infected SW480 cells. SW480 cells were untreated 
(CON) or treated with myriocin and then infected by S. typhimurium wild‑type strain SL1344. Immunoblots were performed on membrane lysates 
with antibody to detect Atg16L1 and NOD2expression, and E‑cadherin for normalization of membrane protein. Representative immunoblots (a) 
and densitometric quantification of immunoreactive bands are shown. The relative band intensities of Atg16L1 (b) and NOD2 (c) in untreated (gray) 
and treated (black) SW480 cells were quantified as fold increases compared with the control cells. Each value represents the mean ± S.E.M. of 3 
independent experiments. An asterisk indicates a significant difference (p < 0.05)
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SL1344 for the time indicated. The activation of the Akt, 
ERK and JNK was examined by using antibodies specific 
to the phosphorylated (activated) forms of these proteins. 
While myriocin had enhanced Salmonella-induced phos-
phorylation of the Akt, it had little or no significant effect 
on activation of the ERK or JNK (Fig. 5). It suggests inhi-
bition of de novo sphingolipid synthesis with myriocin 
may enhance Salmonella-induced anti-apoptosis in IECs 
via Akt.
The involvement of PI3 K/Akt in the Salmonella‑induced 
hBD expression after inhibition of de novo sphingolipid 
synthesis
It was previously demonstrated that the activation of 
PI3 K/Akt suppressed Salmonella-induced IL-8 response 
in IECs [22]. To investigate if PI3  K/Akt play the same 
inhibitory effect on Salmonella-induced hBD-2 response, 
SW480 cells were infected by S. typhimurium wild-type 
strain SL1344 in the presence or absence of LY294002, a 
Fig. 4 Involvement of NOD2 in the suppressive effect of myriocin on Salmonella‑induced hBD‑2 expression in SW480 cells. a Western blots to 
confirm knockdown of NOD2 in SW480 cells. b SW480 cells were transfected with control siRNA or NOD2 siRNA (siRNA = non‑target control siRNA; 
siNOD2 = siRNA to NOD2) for 48 h. The transfected cells were left uninfected (CON) or infected for 1 h with S. typhimurium wild‑type strain SL1344. 
c SW480 cells were infected by S. typhimurium wild‑type strain SL1344 in the absence (methanol as vehicle) or presence of myriocin. Total RNA was 
prepared and analyzed by real‑time quantitative PCR to estimate amounts of hBD‑2 transcript. The amount of hBD‑2 mRNA expression, normal‑
ized to the corresponding amount of GAPDH transcript, is shown as the fold increase over uninfected, control cells. Results are represented as 
mean ± S.E.M. for at least three determinations from independent experiments. An asterisk indicates a significant difference (p < 0.05)
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PI3  K inhibitor. Total RNA was prepared and analyzed 
by real-time quantitative PCR to estimate amounts of 
IL-8 and hBD-2 transcript. The amount of IL-8 and 
hBD-2 mRNA produced, normalized to the correspond-
ing amount of GAPDH transcript, was shown as the fold 
increase over uninfected control (CON) cells. As dem-
onstrated in Fig. 6, similar to previous report, LY294002 
enhanced Salmonella-induced IL-8 mRNA expression 
while it had no effect on Salmonella-induced hBD-2 
mRNA expression in SW480 cells. It was further con-
firmed by the finding that LY294002 did not counteract 
on the suppressive effect of myriocin on Salmonella-
induced hBD-2 in SW480 cells (Fig.  6). It suggests that 
PI3  K/Akt is not involved in the suppressive effect of 
myriocin on Salmonella-induced hBD-2 response in 
IECs.















Fig. 5 Effect of myriocin on Salmonella‑activated intracellular signals in SW480 cells. SW480 cells were left untreated (CON), or treated with 10 µM 
myriocin, and then infected with wild‑type S. Typhimurium strain SL1344 for the times indicated. Activation of the Akt in cell membrane fraction 
and ERK and JNK in cytosolic fraction were analyzed by immunoblotting with antibodies to phosphorylated (p) Akt, ERK and JNK. E‑cadherin and 
GAPDH work as normalization of membranous and cytosolic proteins respectively. The results shown are representative of 3 separate experiments
Fig. 6 The involvement of PI3 K/Akt on Salmonella‑induced IL‑8 and hBD‑2 mRNA expression. SW480 cells were left untreated, or treated with 50 
μM LY294002 (LY). They were then infected with the wild‑type S. Typhimurium strain SL1344 for 1 h. Total RNA was prepared and analyzed by real‑
time quantitative PCR to estimate amounts of IL‑8 and hBD‑2 transcript. The amount of IL‑8 and hBD‑2 mRNA expression, normalized to the cor‑
responding amount of GAPDH transcript, is shown as the fold increase over uninfected, control cells (CON). Results are represented as mean ± S.E.M. 
for at least three determinations from independent experiments. An asterisk indicates a significant difference (p < 0.05)
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To independently corroborate these findings, treatment 
of Caco-2 cells with fumonisin B1, a fungal mycotoxin 
that inhibits ceramide-synthetase activity blocking the 
final step of ceramide synthesis and hence sphingolipid 
biosynthesis, produced similar effect on the Salmonella-
induced membrane recruitment of Atg16L1 and NOD2 
(Additional file 2: Figure S2) as myriocin without affect-
ing the cell viability. To determine whether the functional 
consequences of inhibition of membrane sphingolipid 
was a general phenomenon among different intestinal 
epithelial cell lines, the effect of FB1 on Salmonella-
induced hBD-2 expression was examined in Caco-2 cells. 
Similar results were obtained (Additional file  3: Figure 
S3).
Discussion
Recent studies have begun to implicate sphingolip-
ids in regulation of bacterial infections [1, 2]. Increas-
ing evidence indicates the potential of autophagy 
in controlling infections by directing intracellular 
or ingested pathogens to lysosomes leading to their 
destruction [23]. NOD2 and ATG16L1 recruited to 
the plasma membrane at bacterial entry are critical for 
the autophagic response to invasive bacteria [7, 8]. The 
activated autophagy of epithelial cells by NOD2 and 
Atg16L1 [24] increased killing of Salmonella [25]. Inhi-
bition of de novo sphingolipid synthesis with myriocin 
suppressed the membranous recruitment of NOD2 and 
Atg16L1 (Fig.  3), resulting in reduced autophagic pro-
cess of Salmonella-infected IECs (Fig.  1) and impaired 
clearance of the intracellular bacteria (Fig.  2). It sug-
gests sphingolipids recruiting NOD2 and Atg16L1 into 
plasma membrane of IECs infected by Salmonella infec-
tion contribute to autophagic clearance of invading 
Salmonella. It is compatible with the report [26] that 
fumonisin B1, a ceramide synthases inhibitor, increases 
intestinal colonization by pathogenic Escherichia coli 
in pigs. The abnormalities in the handling of intracel-
lular bacteria through autophagy might play a role in 
Crohn’s disease pathogenesis [24, 27, 28]. The Crohn’s 
disease associated ATG16L1 coding variant shows 
impairment of the capture of internalized Salmonella 
within autophagosomes [28]. Studies with experimental 
animals have shown that feeding sphingolipids inhibits 
colon carcinogenesis and atherosclerosis [29], suggest-
ing that sphingolipids represent a “functional” constitu-
ent of food. The drugs or foods enhancing membrane 
sphingolipids may induce autophagic clearance of 
invading pathogens and lower the risk of Crohn’s 
disease.
NOD2 was reported to serve as an intracellular pat-
tern recognition receptor to enhance host defense 
by inducing the production of antimicrobial peptide 
hBD-2 [9]. An increased risk of inflammatory bowel 
disease (IBD) following enteric infections with Sal-
monella was reported [30]. Dysregulation of NOD2-
mediated defense against invasive pathogens may play 
an important role on the pathogenesis of IBD [31]. 
Colonic hBD2 was dysregulated at mRNA and protein 
level in IBD [32]. The antimicrobial dysfunction (e.g. 
hBD-2) of intestinal epithelial cells to enteric bacteria 
(e.g. pathogenic adherent-invasive E. coli (AIEC)) in 
patients with NOD2 mutants predispose particularly to 
ileal involvement in Crohn’s Disease [27]. Children with 
Crohn’s Disease showed a lower expression of hBD-2 
in the inflamed terminal ileum and ascending colon 
[33]. This study illustrating inhibition of de novo sphin-
golipid synthesis with myriocin suppressed Salmonella-
induced NOD2-mediated hBD-2 expression (Fig.  4), 
links the relationship between membrane sphingolipids 
and inflammatory bowel diseases. In contrast, the syn-
thetic sphingosine analog of myriocin FTY720 leads to 
a specific down-regulation of proinflammatory signals 
while simultaneously inducing functional activity of 
CD4+CD25+ Treg [34]. FTY720 was suggested to offer 
a promising new therapeutic strategy for the treatment 
of IBD. Thus, the role of membrane sphingolipids on 
inflammatory bowel disease is deserved to be investi-
gated in vivo.
Sphingolipid and cholesterol-based structures called 
membrane rafts [35], has received much attention in the 
last few years and are believed to be important struc-
tures for the regulation of many biological and patholog-
ical processes. These structures attract signaling proteins 
and allow these proteins to move to new locations for 
subsequent signaling [36]. It was recently reported 
[11] that nanodomains play a crucial role in trigger-
ing the PI3 K/Akt signaling pathway. However, they did 
not specify the action of sphingolipids and cholesterol. 
Salmonella-induced cholesterol accumulation in Salmo-
nella-containing vacuoles (SCVs) activates PI3  K/Akt 
signaling [37] and subsequently result in an anti-apopto-
sis [12] and anti-inflammatory signal [22], both of which 
may contribute to the invasiveness of Salmonella in IECs 
[37]. As demonstrated in this study that inhibition of de 
novo sphingolipid synthesis with myriocin enhanced the 
phosphorylation of Akt but suppressed the activation of 
ERK, membrane sphingolipids in IECs infected by Sal-
monella may play a contrary role on SCV formation to 
membrane cholesterol [22, 37]. The suppression of phos-
phorylated Akt may contribute to apoptosis of SCV lead-
ing to damaged SCV, which is directed for autophagic 
clearance. Likewise, although PI3  K/Akt was involved 
in membrane cholesterol-induced anti-inflammatory 
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response but it is not involved in the effect of depletion 
of sphingolipids on Salmonella-induced hBD-2 expres-
sion (Figs. 4c, 6), which is mediated by NOD2 (Fig. 4b). 
It is very important for the pathogenesis of Salmonella 
infection or innate immunity of the host to defense 
against the invasive bacteria by regulating the homeo-
stasis between cholesterol and sphingolipids [38]. It is 
a novel and promising finding that provides therapeutic 
strategy to enhance sphingolipids beyond cholesterol, in 
order to enrich innate immunity to Salmonella infection.
Conclusion
Altogether, we demonstrated inhibition of de novo sphin-
golipid synthesis by myriocin, in one way, enhanced the 
activation of Akt which is important to maintain intact 
SCV; and in another way, interfered with the recruit-
ment of NOD2 and ATG16L1 into membrane resulting 
in impairment of autophagy and suppression of hBD-2. 
It suggests membrane sphingolipids at the entry site of 
Salmonella recruited NOD2 and ATG16L1 to the mem-
brane, inhibit activation of Akt signaling, resulting in the 
autophagy of the apoptotic SCV and enhanced NOD2-
mediated hBD-2 expression. Because manipulating 
sphingolipids in host cells affects infection and inflam-
mation by the pathogens, pharmacological agents aiming 
to regulate sphingolipids or diet enriched with sphin-
golipids [29] could be potentially used in the treatment of 
infectious or inflammatory bowel diseases in the future.
Methods
Reagents
Stock solutions of myriocin and fumonisin B1 (FB1) were 
prepared as follows: myriocin 1 mg/ml in methanol; FB1, 
10 mM in DMSO (all from Sigma, St. Louis, MO).
Bacterial strain
The wild-type Salmonella enterica serovar Typhimurium 
(S. Typhimurium) strain used in this work was SL1344. 
The preparation of Salmonella inoculum has been 
described previously [14, 39].
Cell culture and infection
Caco-2, and SW480 cells were purchased from the Amer-
ican Type Culture Collection (Manassas, VA, USA) and 
were cultured as described previously [14, 37, 39] or as 
recommended by the manufacturer.
Inhibition of de novo sphingolipid synthesis
To inhibit sphingolipids synthesis, cells were allowed to 
attach overnight and were then cultivated in DMEM con-
taining 10 µM myriocin for 48 h as previously described 
[16]. Cells were stained with Rhodamine 123 (10 μg/ml, 
10 min) to confirm that the treatment with inhibitors was 
not lethal. For lipid analysis, lipids from roughly 2 × 106 
cells were extracted and were resolved by two sequen-
tial thin layer chromatography (TLC) runs according to 
Poole et al. [16] with some modification.
Cell fractionation
Cytosolic and membrane fractions were prepared as pre-
viously described [14, 37, 39] with some modification. 
The protein concentration of extracts was normalized 
before analysis.
Western blotting
Equal amounts of protein were analyzed by immu-
noblot as previously described [14, 37, 39]. The trans-
ferred membranes were probed with primary antibodies 
against phosphorylated (p-)Akt (Cell Signaling, Beverly, 
MA), (p-)ERK (Santa Cruz Biotechnology, Santa Cruz, 
CA) or (p-)JNK (New England BioLabs, Beverly, MA), 
or anti-ATG16L1, LC3B (Cell Signaling, Beverly, MA) 
or NOD2 (Cayman Chemical, Ann Arbor, MI). After 
washes, the membranes were incubated with appropri-
ate horseradish peroxidase-associated secondary anti-
bodies before signals were visualized with the enhanced 
chemiluminescence detection system (Amersham 
Bioscience).
hBD‑2 assay
After treatment or infection, the culture media were col-
lected and analyzed for hBD-2 by enzyme-linked immu-
nosorbent assay (ELISA) as manufacturer’ s instructions 
with some modification [40].
Real‑time Reverse Transcription PCR
Total RNA was prepared from control or infected cells. 
Transcripts were amplified after reverse transcription 
with random hexamers using the GeneAmp kit (Roche, 
Nutley, NJ). Real-time reverse transcription-PCR analy-
ses were performed in a fluorescence temperature cycler 
(LightCycler; Roche Diagnostics) as described previously 
[14, 37, 39]. For hBD-2, the primers were as follows: for-
ward, 5′-ATCAGCCATGAGGGTCTTGT-3′ and reverse, 
5′-GAGACCACAGGTGCCAATTT-3′. For NOD2, the 
primers were as follows: forward, 5′-AGCCATTGTCAG-
GAGGCTC-3′ and reverse, 5′-CGTCTCTGCTCCAT-
CATAGG-3′. All quantifications were normalized to the 
housekeeping gene glyceraldehyde-3-phosphate dehy-
drogenase. Relative expression is given as a ratio between 
target gene expression and glyceraldehyde-3-phosphate 
dehydrogenase expression.
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Immunofluorescence analysis
After infection and treatment, the cultured SW480 cells 
were fixed, permeabilized and incubated with rabbit anti-
LC3B (Cell Signaling Technology, Danvers, MA) (1:250). 
Secondary antibody was goat anti-rabbit IgG conjugated 
with Alexa Fluor 594 fluorochrome (Invitrogen Molecu-
lar Probes, Eugene, OR, USA). Nuclei were counter-
stained with fluorescent dye Hoechst (Sigma Aldrich, St. 
Louis, MO, USA). The percentage of cells with endoge-
nous LC3 punctae was determined by counting the num-
ber of positively staining cells from 100 randomly chosen 
cells from three separate experiments.
RNA interference (RNAi) in SW480 cells
RNAi experiments in SW480 cells were done as described 
previously [14, 39], including control nonsilencing small 
interference RNA (siRNA), NOD2siRNA and different 
siRNAs targeting Atg16L1 (sequence 1: sense GAGUUGU 
CUUCAGCCCUGAUGGCAG, antisense CUGCCAUC 
AGGGCUGAAGACAACUC; sequence 2: sense GGCUC 
UGCUGAGGGCUCUCUGUAUA, antisense UAUACA 
GAGAGCCCUCAGCAGAGCC; sequence 3: sense CA 
AGGGUUCCCUAUCUGGCAGUAAU, antisense AUU 
ACUGCCAGAUAGGGAACCCUUG (sequence were 
purchased from Invitrogen Corporation, Carlsbad, CA, 
USA).  Briefly, cultured SW480 cells were transfected 
with chemically synthesized siRNA to silence NOD2 and 
Atg16L1, respectively. Immunoblotting were performed 
to examine the efficiency of protein knockdown. For 
the SW480 cells, 20 nM of each siRNA was transfected 
48–96 h before S. typhimurium infection.
Gentamicin protection assay
SW480 cells were pre-treated and infected, then gen-
tamicin protection assay were undertaken as described 
previously [37].
Cell viability and morphologic features
Representative cell populations from each condition were 
examined under light microscopy. No significant change 
was noted under any condition. Cells were stained with 
Rhodamine 123 (Santa Cruz Biotechnology, Santa Cruz, 
CA) to confirm that the treatment with inhibitors was 
not lethal.
Statistical analysis
All experiments were carried out at least three times with 
similar results. Statistical significance was determined 
using the student’s t-test.
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